Compare GRFS & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | PFSI |
|---|---|---|
| Founded | 1940 | 2008 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.7B |
| IPO Year | N/A | 2018 |
| Metric | GRFS | PFSI |
|---|---|---|
| Price | $8.27 | $92.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $10.15 | ★ $128.11 |
| AVG Volume (30 Days) | ★ 573.0K | 436.1K |
| Earning Date | 07-28-2022 | 05-05-2026 |
| Dividend Yield | ★ 1.80% | 1.35% |
| EPS Growth | N/A | ★ 59.25 |
| EPS | N/A | ★ 9.30 |
| Revenue | N/A | ★ $984,629,000.00 |
| Revenue This Year | $4.49 | N/A |
| Revenue Next Year | $6.42 | $16.96 |
| P/E Ratio | $18.67 | ★ $9.89 |
| Revenue Growth | N/A | ★ 3.05 |
| 52 Week Low | $7.08 | $82.65 |
| 52 Week High | $11.14 | $160.36 |
| Indicator | GRFS | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 53.94 |
| Support Level | $7.64 | $91.78 |
| Resistance Level | $8.88 | $95.79 |
| Average True Range (ATR) | 0.18 | 2.15 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 38.54 | 50.21 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.